227 related articles for article (PubMed ID: 37157199)
1. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
Curr Med Chem; 2024; 31(19):2732-2750. PubMed ID: 37157199
[TBL] [Abstract][Full Text] [Related]
2. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
[TBL] [Abstract][Full Text] [Related]
4. [Intrathecal chemotherapy for leptomeningeal metastases in patients with breast cancer].
Moskvina EA; Belov DM; Naskhletashvili DR; Mekheda LV; Bekyashev AK; Aleshin VA; Gasparyan TG; Mitrofanov AA; Sevyan NV; Prozorenko EV; Tkhazeplov AA; Roshchina KE
Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(3):31-37. PubMed ID: 38881013
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
7. Therapy of leptomeningeal metastasis in solid tumors.
Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
[TBL] [Abstract][Full Text] [Related]
8. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
9. [Leptomeningeal carcinomatosis as a rare metastatic spreading of BRAF-mutated microsatellite stable colon cancer].
Höblinger A; Weber S; Tschirner F; Kröber S; Streetz K
Z Gastroenterol; 2017 Jul; 55(7):667-674. PubMed ID: 28709170
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
11. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
13. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
Kordbacheh T; Law WY; Smith IE
Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.
Beauchesne P
Lancet Oncol; 2010 Sep; 11(9):871-9. PubMed ID: 20598636
[TBL] [Abstract][Full Text] [Related]
15. Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosis.
Perissinotti AJ; Reeves DJ
Ann Pharmacother; 2010 Oct; 44(10):1633-40. PubMed ID: 20807868
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Salgia S; Fleming GF; Lukas RV
J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
[TBL] [Abstract][Full Text] [Related]
17. A new approach for leptomeningeal metastases: chemotherapy administered through lumbar intrathecal port.
Comlek S; Saglam S
Arq Neuropsiquiatr; 2021 Sep; 79(9):816-823. PubMed ID: 34669821
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
Wasserstrom WR; Glass JP; Posner JB
Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
[TBL] [Abstract][Full Text] [Related]
19. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
[TBL] [Abstract][Full Text] [Related]
20. Breast leptomeningeal disease: a review of current practices and updates on management.
Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]